Evidence map›Paper›PMID 41464936›Full record

ArticleFoods (Basel, Switzerland)2025

Evaluation of Potential Anti-Diabetic Synbiotic Formulation of

Hyewon Choe, Chae Young Shin, Jung Sik Lim, Jung-Soo Park, Joo-Woong Park, Woo Jung Kim, Yong Il Park, Jin Ree

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hyewon ChoeBiostream Co., Ltd., Suwon 10442, Republic of Korea.ORCID 0009-0009-8463-5460
Chae Young ShinDepartment of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Jung Sik LimDepartment of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Jung-Soo ParkBiostream Co., Ltd., Suwon 10442, Republic of Korea.
Joo-Woong ParkBiostream Co., Ltd., Suwon 10442, Republic of Korea.
Woo Jung KimBiocenter, Gyeonggi-do Business and Science Accelerator, Suwon 16229, Republic of Korea.
Yong Il ParkDepartment of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon 14662, Republic of Korea.ORCID 0000-0002-1749-0689
Jin ReeBiostream Co., Ltd., Suwon 10442, Republic of Korea.

Funding

Gyeonggido Business & Science Accelerator (GBSA)
6 · The paper itself

Abstract

Probiotics have been studied for their potential to treat chronic diseases. This study examined the use of

Indexed as

Lacticaseibacillus rhamnosusmicrobiome diversityprobioticsprobiotics propertiessymbioticstype 2 diabetes mellitus

Identifiers

PMID41464936
PMCPMC12731962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.